Srinivas Nanduri (Nanduri Srinivas)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Venues

Archiv der Pharmazie

RSC medicinal chemistry

RSC advances

Future medicinal chemistry

Albany Molecular Research Inc

Sri Sathya Sai Institute of Higher Learning (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Albany Molecular Research Inc May 23 2012 - Jun 06 2013

India

Director :: Medicinal Chemistry

Aurigene Discovery Technologies Ltd Dec 17 2008 - May 16 2012

India

Research Director :: Medicinal Chemistry

Biocon Bristol-Myers Squibb Research and Development Center Mar 03 2008 - Dec 11 2008

India

Chief Scientific Manager :: Medicinal Chemistry

Dr. Reddy's Laboratories (India) Sep 11 1995 - Feb 29 2008

India

Principal Research Investigator :: Medicinal Chemistry

Sri Sathya Sai Institute of Higher Learning Jan 01 1992 - Aug 31 1995

India

Lecturer :: Chemistry

Education History

Sri Sathya Sai Institute of Higher Learning Jun 01 1988 - Nov 22 1991

India

PHD :: chemistry

Sri Sathya Sai Institute of Higher Learning Jun 01 1986 - Mar 31 1988

India

MSC :: Chemistry

Sri Sathya Sai Institute of Higher Learning Jun 01 1983 - Mar 31 1986

India

BSC :: Chemistry

Publications

Sarvan Maddipatla, Bulti Bakchi, Rutuja Rama Gadhave, Andrea Ammara, Shashikanta Sau, Bandela Rani, Srinivas Nanduri, Nitin Pal Kalia, Claudiu T Supuran, Venkata Madhavi Yaddanapudi
Exploring rhodanine linked enamine-carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies. Archiv der Pharmazie 357 (7) (2024)
Preeti Rana, Ramulu Parupalli, Abdul Akhir, Deepanshi Saxena, Rahul Maitra, Mohmmad Imran, Pradip Malik, Shaik Mahammad Ghouse, Swanand Vinayak Joshi, Danaboina Srikanth, Venkata Madhavi Yaddanapudi, Arunava Dasgupta, Sidharth Chopra, Srinivas Nanduri
Synthesis and biological evaluation of new naphthalimide-thiourea derivatives as potent antimicrobial agents active against multidrug-resistant Staphylococcus aureus and Mycobacterium tuberculosis . RSC medicinal chemistry 15 (4) (2024)
Siva Kumar Rokkam, Manohar Bhujel, Dolly Jain, Lakshminath Sripada, Srinivas Nanduri, Avinash Bajaj, Nageswara Rao Golakoti
Synthesis of novel pyrazole acetals of andrographolide and isoandrographolide as potent anticancer agents. RSC advances 14 (36) (2024)
Sarvan Maddipatla, Bulti Bakchi, Rutuja Rama Gadhave, Andrea Ammara, Shashikanta Sau, Bandela Rani, Srinivas Nanduri, Nitin Pal Kalia, Claudiu T Supuran, Venkata Madhavi Yaddanapudi
Exploring rhodanine linked enamine-carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies. Archiv der Pharmazie (2024)
Preeti Rana, Ramulu Parupalli, Abdul Akhir, Deepanshi Saxena, Rahul Maitra, Mohmmad Imran, Pradip Malik, Shaik Mahammad Ghouse, Swanand Vinayak Joshi, Danaboina Srikanth, Venkata Madhavi Yaddanapudi, Arunava Dasgupta, Sidharth Chopra, Srinivas Nanduri
Synthesis and biological evaluation of new naphthalimide-thiourea derivatives as potent antimicrobial agents active against multidrug-resistant Staphylococcus aureus and Mycobacterium tuberculosis . RSC medicinal chemistry 15 (4) (2024)
Siva Kumar Rokkam, Manohar Bhujel, Dolly Jain, Lakshminath Sripada, Srinivas Nanduri, Avinash Bajaj, Nageswara Rao Golakoti
Synthesis of novel pyrazole acetals of andrographolide and isoandrographolide as potent anticancer agents. RSC advances 14 (36) (2024)
Bulti Bakchi, Sarvan Maddipatla, Khushi Gupta, Anuradha Singampalli, Deepanshi Saxena, Rahul Maitra, Puja K Agnivesh, Nitin P Kalia, Srinivas Nanduri, Siddharth Chopra, Venkata Madhavi Yaddanapudi
Facile one-pot synthesis of N-pyridinylaminonaphthol derivatives and their antibacterial evaluation against multidrug-resistant Staphylococcus aureus. Archiv der Pharmazie (2024)
Ojaswitha Ommi, Niccolò Paoletti, Alessandro Bonardi, Paola Gratteri, Harshada Anil Bhalerao, Shashikanta Sau, Srinivas Nanduri, Arifuddin Mohammed, Nitin Pal Kalia, Rajesh Sonti, Claudiu T Supuran, Venkata Madhavi Yaddanapudi
Exploration of 3-aryl pyrazole-tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors. Archiv der Pharmazie (2023)
Shaik Mahammad Ghouse, Kareena Sinha, Alessandro Bonardi, Gaurav Pawar, Satyaveni Malasala, Srikanth Danaboina, Arifuddin Mohammed, Venkata Madhavi Yaddanapudi, Claudiu T Supuran, Srinivas Nanduri
6-Aminocoumarin oxime-ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies. Archiv der Pharmazie (2023)
Ojaswitha Ommi, Mohammad Naiyaz Ahmad, Siva Nageswara Rao Gajula, Parita Wanjari, Shashikanta Sau, Puja Kumari Agnivesh, Santosh Kumar Sahoo, Nitin Pal Kalia, Rajesh Sonti, Srinivas Nanduri, Arunava Dasgupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi
Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant Staphylococcus aureus and Mycobacterium tuberculosis . RSC medicinal chemistry 14 (7) (2023)
Mohmmad Imran, Mohammad Naiyaz Ahmad, Arunava Das Gupta, Preeti Rana, Srinivas Nanduri, Sidharth Chopra
Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens. Future medicinal chemistry 14 (15) (2022)
Ramulu Parupalli, Ravikumar Akunuri, Grace Kaul, Abdul Akhir, Deepanshi Saxena, Shaik Mahammad Ghouse, Venkata Madhavi Yaddanapudi, Sidharth Chopra, Srinivas Nanduri
Serendipitous identification of phenylhydrazine derivatives as potent inhibitors of carbapenem-resistant Acinetobacter baumannii . Future medicinal chemistry 14 (22) (2022)
Santosh Kumar Sahoo, Mohammad Naiyaz Ahmad, Grace Kaul, Srinivas Nanduri, Arunava Dasgupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi
Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy. RSC medicinal chemistry 13 (5) (2022)
Nitesh Tamang, Christopher Andrews, Sai Kiran Mavileti, Srinivas Nanduri, Nageswara Rao Golakoti, Balasubramanyam Karanam
Anti-cancer activity of heteroaromatic acetals of andrographolide and its isomers. New journal of chemistry = Nouveau journal de chimie 46 (20) (2022)
Santosh Kumar Sahoo, Siva N R Gajula, Mohammad N Ahmad, Grace Kaul, Srinivas Nanduri, Rajesh Sonti, Arunava Dasgupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi
Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents. Archiv der Pharmazie 355 (11) (2022)
Santosh Kumar Sahoo, Mohammad Naiyaz Ahmad, Grace Kaul, Srinivas Nanduri, Arunava Das Gupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi
Exploration of Isoxazole-Carboxylic Acid Methyl Ester Based 2-Substituted Quinoline Derivatives as Promising Antitubercular Agents. Chemistry & biodiversity 19 (7) (2022)
Satyaveni Malasala, Anusha Polomoni, Sai Manohar Chelli, Swayamsidda Kar, Y V Madhavi, Srinivas Nanduri
A microwave-assisted copper-mediated tandem approach for fused quinazoline derivatives. Organic & biomolecular chemistry 19 (8) (2021)
Nikhil B Gaikwad, Sapana Bansode, Shankar Biradar, Mayuri Ban, Srinivas Nanduri, Chandraiah Godugu, Venkata Madhavi Yaddanapudi
New 3-(1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one-based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis-inducing agents. Archiv der Pharmazie 354 (11) (2021)
Saiprasad Nunewar, Sanjeev Kumar, Harishchandra Pandhare, Srinivas Nanduri, Vinaykumar Kanchupalli
Rh(III)-Catalyzed Chemodivergent Annulations between Indoles and Iodonium Carbenes: A Rapid Access to Tricyclic and Tetracyclic N-Heterocylces. Organic letters 23 (11) (2021)
Nikhil B Gaikwad, Krishna Nirmale, Santosh K Sahoo, Mohammad N Ahmad, Grace Kaul, Manjulika Shukla, Srinivas Nanduri, Arunava Das Gupta, Sidharth Chopra, Venkata Madhavi Yaddanapudi
Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents. Archiv der Pharmazie 354 (5) (2020)
Satyaveni Malasala, Jitendra Gour, Md Naiyaz Ahmad, Srikanth Gatadi, Manjulika Shukla, Grace Kaul, Arunava Dasgupta, Y V Madhavi, Sidharth Chopra, Srinivas Nanduri
Copper mediated one-pot synthesis of quinazolinones and exploration of piperazine linked quinazoline derivatives as anti-mycobacterial agents. RSC advances 10 (71) (2020)
Jitendra Gour, Srikanth Gatadi, Ravikumar Akunuri, Madhavi Venkata Yaddanapudi, Mushtaq Ahmad Nengroo, Dipak Datta, Sidharth Chopra, Srinivas Nanduri
Catalyst-free facile synthesis of polycyclic indole/pyrrole substituted-1,2,3-triazoles. Organic & biomolecular chemistry 17 (35) (2019)
Jitendra Gour, Srikanth Gatadi, Satyaveni Malasala, Madhavi Venkata Yaddanpudi, Srinivas Nanduri
A Microwave-Assisted SmI2-Catalyzed Direct N-Alkylation of Anilines with Alcohols. The Journal of organic chemistry 84 (11) (2019)
Tim H Holmström, Anu-Maarit Moilanen, Tarja Ikonen, Mari L Björkman, Tero Linnanen, Gerd Wohlfahrt, Stefan Karlsson, Riikka Oksala, Timo Korjamo, Susanta Samajdar, Srinivasan Rajagopalan, Shekar Chelur, Kishore Narayanan, Raghuveer K Ramachandra, Jiju Mani, Rashmi Nair, Nagaraj Gowda, Thomas Anthony, Samiulla Dhodheri, Subhendu Mukherjee, Ravi K Ujjinamatada, Srinivas Nanduri, Murali Ramachandra, Pekka J Kallio
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity. Molecular cancer therapeutics 18 (1) (2018)

Srinivas Nanduri.css-eqlu8i{font-size:small;padding-left:4px;} (Nanduri Srinivas)

Publication Activity (10 Years)

Top Topics

Top Venues

Srinivas Nanduri (Nanduri Srinivas)